This Mid-Blend Fund Seeks Diamonds in the Rough
Silver-rated First Eagle Fund of America has driven strong returns by rooting out companies with unrecognized potential.
Silver-rated First Eagle Fund of America has driven strong returns by rooting out companies with unrecognized potential.
Greg Carlson: This week's Morningstar Medalist is First Eagle Fund of America (FEAFX). This fund resides in Morningstar's mid-blend category. However, the overall portfolio tends to own a mix of mid- and large-cap stocks. The managers typically buy mid-cap stocks; however, a lot of their winners will blossom into large-cap territory, and they continue to hold on for the long haul as long as things work well. So, you might say that they start out as value investors but end up holding some stocks that are classified as growth stocks, such as Valeant Pharmaceuticals (VRX), for example, which is a biotech company.
They invest in companies that are undergoing corporate change. These typically are companies that have had management changes or some type of restructuring. They also look for companies that have some sort of hidden asset that hasn't been recognized by the market.
The management team has been quite stable over time. However, one of the two managers who have been on the fund for 25 years has stepped back in his role a bit--reduced his day-to-day management. In his place is a new comanager named in 2014, Eric Stone. He has only been at the firm for three years, but he has been familiar with the firm for over a decade, working for a former co-worker of theirs.
Long-term, risk-adjusted, and total returns have been very strong here. We think this is a solid holding, and it earns a Morningstar Analyst Rating of Silver.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.